EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSACLG00000004241
Gene Symbol: ALOX5AP
3 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSACLG00000025968
Gene Symbol: AVPR1A
3 Cross references
203 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSACLG00000012998
Gene Symbol: AVPR1A
3 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSACLG00000003982
Gene Symbol: AVPR2
3 Cross references
210 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSACLG00000015327
Gene Symbol: AVPR2
1 Cross references
165 Possible Orthologues:

Aromatase

Ensembl ID : ENSACLG00000018805
Gene Symbol: LOC113020014
3 Cross references
252 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSACLG00000006710
Gene Symbol: LOC113014284
3 Cross references
194 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2-Like

Ensembl ID : ENSACLG00000027485
Gene Symbol: LOC113026027
2 Cross references
186 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSACLG00000019599
Gene Symbol: AURKA
3 Cross references
230 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSACLG00000003796
Gene Symbol: LOC113008948
3 Cross references
205 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSACLG00000009393
Gene Symbol: LOC113033745
3 Cross references
197 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSACLG00000001339
Gene Symbol: LOC113034504
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).